HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Down-regulation of T cell responses to AChR and reversal of EAMG manifestations in mice by a dual altered peptide ligand via induction of CD4+ CD25+ regulatory cells.

Abstract
A dual altered peptide ligand (APL) composed of the tandemly arranged two single amino acid analogs of two myasthenogenic peptides, p195-212 and p259-271 was demonstrated to down-regulate in vitro and in vivo myasthenia gravis (MG) associated autoreactive responses. In this study, we demonstrate the suppressive properties of the dual APL following immunization with the whole Torpedo AChR (TAChR) and in mice with established experimental autoimmune MG (EAMG). The dual APL acts by up-regulating CD4+ CD25+ cells expressing characteristic regulatory markers along with an associated increase in levels of IL-10 and TGF-beta. The latter cytokine plays a key role in the ameliorating effects of the dual APL.
AuthorsBadiga Venkata Aruna, Michael Sela, Edna Mozes
JournalJournal of neuroimmunology (J Neuroimmunol) Vol. 177 Issue 1-2 Pg. 63-75 (Aug 2006) ISSN: 0165-5728 [Print] Netherlands
PMID16757035 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Ligands
  • Peptides
  • Receptors, Interleukin-2
  • Receptors, Nicotinic
  • Transforming Growth Factor beta
  • dual altered peptide ligand
  • Interleukin-10
Topics
  • Animals
  • Autoimmunity (drug effects, immunology)
  • Biomarkers (metabolism)
  • CD4-Positive T-Lymphocytes (drug effects, immunology)
  • Cells, Cultured
  • Disease Models, Animal
  • Down-Regulation (drug effects, immunology)
  • Female
  • Immunosuppression Therapy (methods)
  • Interleukin-10 (immunology, metabolism)
  • Ligands
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Myasthenia Gravis, Autoimmune, Experimental (immunology, physiopathology, therapy)
  • Peptides (pharmacology)
  • Receptors, Interleukin-2 (biosynthesis)
  • Receptors, Nicotinic (immunology)
  • Subcellular Fractions
  • Torpedo
  • Transforming Growth Factor beta (immunology, metabolism)
  • Treatment Outcome
  • Up-Regulation (drug effects, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: